1
项与 NB004 (Ningbo Xinwan) 相关的临床试验A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB004 Administered as Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors
This is a Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB004 Administered as Monotherapy or Combination Therapy in Subjects with Advanced Solid Tumors
100 项与 NB004 (Ningbo Xinwan) 相关的临床结果
100 项与 NB004 (Ningbo Xinwan) 相关的转化医学
100 项与 NB004 (Ningbo Xinwan) 相关的专利(医药)
100 项与 NB004 (Ningbo Xinwan) 相关的药物交易